Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biospecifics Technologies Corp (NASDAQ:BSTC)

42.75
Delayed Data
As of 1:56pm ET
 -0.14 / -0.33%
Today’s Change
41.95
Today|||52-Week Range
58.79
-23.25%
Year-to-Date
New Strong Sell Stocks for November 17th
Nov 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close42.89
Today’s open42.87
Day’s range42.53 - 43.12
Volume27,313
Average volume (3 months)23,327
Market cap$307.3M
Dividend yield--
Data as of 1:56pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+18.18%
Earnings growth (this year)+0.64%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+15.39%
P/E ratio26.9
Price/Sales15.45
Price/Book5.45

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc+0.45+7.69%
CLXTCalyxt Inc+0.11+0.59%
ARWRArrowhead Pharmaceut...-0.05-1.36%
AVXLAnavex Life Sciences...+0.02+0.46%
Data as of 2:10pm ET, 11/21/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)$0.42
Annual revenue (last year)$26.3M
Annual profit (last year)$11.4M
Net profit margin43.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
Thomas L. Wegman
Corporate headquarters
Lynbrook, New York

Forecasts